Metabolomic Profiles of Scleroderma-PAH are different than idiopathic PAH and associated with worse clinical outcomes
Mona Alotaibi(University of California System), Mohit Jain(BioMarin (United Kingdom)), Timothy M. Fernandes(University of California System), Susan Cheng(Cedars-Sinai Medical Center), Stephen Y. Chan(University of Pittsburgh Medical Center), Jason X.‐J. Yuan(Scripps Research Institute), William C. Nichols(Cincinnati Children's Hospital Medical Center), Atul Malhotra(Monash Health), Laith Alshawabkeh(UC San Diego Health System), Anna R. Hemnes(Vanderbilt University Medical Center), Ankit A. Desai(Indiana University – Purdue University Indianapolis), Kim M. Kerr(University of California San Diego), Michael W. Pauciulo(Center for Human Genetics), Tao Long(Human Longevity (United States)), Nick H. Kim(University of California San Diego), Junzhe Shao(Peking University), Jeramie D. Watrous(University of California San Diego)
Cited by 0
Related Papers
Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
|Circulation|2020|9.4k
Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
|Circulation|2019|9.1k
Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association
|Circulation|2018|7.2k
Heart Disease and Stroke Statistics—2021 Update
|Circulation|2021|5.7k
Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking
|Nature Biotechnology|2016|4.7k